Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Change in Account Payables (2021 - 2025)

Historic Change in Account Payables for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to -$338238.9.

  • Molecular Partners Ag's Change in Account Payables rose 8097.02% to -$338238.9 in Q3 2025 from the same period last year, while for Sep 2025 it was $585988.3, marking a year-over-year increase of 15927.05%. This contributed to the annual value of $595631.6 for FY2024, which is 16506.71% up from last year.
  • As of Q3 2025, Molecular Partners Ag's Change in Account Payables stood at -$338238.9, which was up 8097.02% from $326497.6 recorded in Q2 2025.
  • Molecular Partners Ag's Change in Account Payables' 5-year high stood at $5.2 million during Q2 2021, with a 5-year trough of -$5.5 million in Q4 2022.
  • Moreover, its 5-year median value for Change in Account Payables was $774.13 (2025), whereas its average is -$217390.7.
  • As far as peak fluctuations go, Molecular Partners Ag's Change in Account Payables plummeted by 40797.27% in 2022, and later surged by 17462.66% in 2024.
  • Molecular Partners Ag's Change in Account Payables (Quarter) stood at $1.8 million in 2021, then tumbled by 407.97% to -$5.5 million in 2022, then soared by 83.47% to -$915352.1 in 2023, then surged by 165.22% to $596955.4 in 2024, then plummeted by 156.66% to -$338238.9 in 2025.
  • Its Change in Account Payables was -$338238.9 in Q3 2025, compared to $326497.6 in Q2 2025 and $774.13 in Q1 2025.